Steinau S
It functions as a triple monoamine reuptake inhibitor, affecting serotonin, norepinephrine, and dopamine neurotransmission in the brain
Forms include bovine, marine, chicken sources with minimal difference in efficacy
The applied rationale of skin and colon wounds (Seiwerth et al., 1997) covers the different healing patterns and dynamics of these organs related to their collagen structures (Seiwerth et al., 1997)
Its a value-add, not a replacement for actual movementthink bonus stimulus, not miracle machine
Theoretical synergy: three pathways working together Triple-pathway hypothesis: Why it might work: Non-overlapping receptor pathways Complementary not redundant Multiple appetite suppression mechanisms Enhanced metabolic effects Potential for greater weight loss than either alone Comparison to proven combinations: CagriSema (semaglutide + cagrilintide): 15-25% proven Tirzepatide alone: 15-22% proven Theoretical tirzepatide + cagrilintide: 20-30% unproven The critical problem: no clinical data What we DON'T know: Is the combination safe